ECE2021 Audio Eposter Presentations General Endocrinology (51 abstracts)
The effect of COVİD-19 process on patients with endocrinological disease in a pandemic hospital: What Happened to the others?
Evin Bozkur 1 , Seda Turgut 1 , Naim Pamuk 1 , Hamide Piskinpasa 2 , Duygu Metin 3 , Cem Dural 4 , Nuri Alper Sahbaz 4 , Omur Gunaldı 5 , İlkay Cakir 1 , Meral Mert 1 & Sema Ciftci Dogansen 2
1University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Endocrinology and Metabolism, İstanbul, Turkey; 2University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey; 3University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Radiology, İstanbul, Turkey; 4University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Surgery, İstanbul, Turkey; 5University of Health Sciences, Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Neurology, Neurosurgery and Psychiatry, Department of Neurosurgery, İstanbul, Turkey
Objective
To evaluate the effects of the pandemic process on those with an endocrinological disease that will require close follow-up from the last visit before the pandemic.
Design
This was a retrospective study.
Methods
Patients of 3903 with thyroid, calcium-bone metabolism, adrenal gland, pituitary diseases, and neuroendocrine tumor (NET) were retrospectively scanned. The remaining 855 (656F/199M) patients with active disease or still needed the multidisciplinary approaches were included in the study. How many patients who continued the disease-related medical procedures could complete these procedures on time in the pandemic period were determined, and the medical deprivation rate (MDR) was calculated.
Results
The pre-pandemic period of our patients with thyroid disease (n = 594), calcium-bone metabolism disorder (n = 130), adrenal disease (n = 85), pituitary disease and NET (n = 46), had MDR 85%, 56%, 81% and 89%, respectively. For each subgroup of the patients; the lowest MDR (67%) was in medullary thyroid carcinoma, the highest MDR (89%) was in differentiated thyroid carcinoma; the lowest MDR (6%) was in osteoporosis, the highest MDR (100%) was in the active Paget’s disease; the lowest MDR (0%) was in primary adrenocortical insufficiency, the highest MDR (100%) was in hyperfunction adrenal adenomas; the lowest MDR (81%) was in the pituitary incidentaloma or non-functional adenomas, and the highest MDR (100%) was in Cushing’s disease, active prolactinoma, TSHoma, and NET, respectively.
Conclusion
This study analyzed the medical deprivations experienced by patients with endocrinological diseases during the pandemic period and showed that these patients’ follow-up and treatment should not be underestimated during the pandemic period.
Discussion
With the decrease in the number of COVID-19 cases in countries affected by the pandemic, the impact of patients with other diseases who experienced medical deprivation became more prominent.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more